Comparison of the number of WGM cell-injected mice that rejected the second tumor challenge with WEHI3B cells between WT and BLT1-KO mice
| . | Mice that rejected first tumor challenge, no. (%)* . | Mice that rejected second tumor challenge, no. (%)† . |
|---|---|---|
| Female groups‡ | ||
| WT/WGM | 30/35 (85.7) | 9/30 (30.0)§ |
| KO/WGM | 16/16 (100) | 13/16 (81.3)§ |
| Male groups | ||
| WT/WGM | 0/6 (0) | — |
| KO/WGM | 6/6 (100) | 5/6 (83.3)§ |
| . | Mice that rejected first tumor challenge, no. (%)* . | Mice that rejected second tumor challenge, no. (%)† . |
|---|---|---|
| Female groups‡ | ||
| WT/WGM | 30/35 (85.7) | 9/30 (30.0)§ |
| KO/WGM | 16/16 (100) | 13/16 (81.3)§ |
| Male groups | ||
| WT/WGM | 0/6 (0) | — |
| KO/WGM | 6/6 (100) | 5/6 (83.3)§ |